Journals / Turkish Thoracic Journal / 2019 / Cilt: 20 - Sayı: 1

Efficacy and Safety of Stent, Valves, Vapour ablation, Coils and Sealant Therapies in Advanced Emphysema: A Meta-Analysis

Pages
43–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, characterization of patients who would be most benefited from these procedures is required, and effectiveness of these procedures in long run needs to be established.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bronchoscopic lung volume reduction (BLVR) methods have emerged as a new treatment option for patients with severe emphysema.Endobronchial valves and coils have been extensively studied.
📊
Key Findings & Data:Databases were searcheduntil October 2016, and randomized controlled trials (RCTs) comparing available BLVR procedures to standard medical care or shambronchoscopy were included.
💡
Conclusion & Impact:However, characterization of patients who would be most benefited from these procedures is required, and effectiveness of these procedures in long run needs to be established.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Bronchoscopic lung volume reduction (BLVR) methods have emerged as a new treatment option for patients with severe emphysema.Endobronchial valves and coils have been extensively studied. This review assesses efficacy, safety, and cost effectiveness of the BLVRprocedures (stent, valves, vapor ablation, endobronchial coils, lung sealant) in patients with severe emphysema. Databases were searcheduntil October 2016, and randomized controlled trials (RCTs) comparing available BLVR procedures to standard medical care or shambronchoscopy were included. Random effect model and generic inverse variance approach were used for meta-analysis. Out of 381identified records, 16 RCTs were included. As compared to recommended medical care or sham bronchoscopy, the BLVR proceduresare more effective in improving quality of life [SGRQ score (WMD=−6.38; −9.12 to −3.65)] and 6MWT (WMD=24.21; 9.68-38.74)and percentage FEV1 (WMD=10.48; 7.07-13.89). Increased risk of serious adverse events (RR=2.18; 1.63–2.93), specifically for chronicpulmonary obstructive disease exacerbations and lower respiratory tract infection combined (RR=1.37; 1.07-1.75), were observed withbronchoscopic interventions, while there was no difference in number of deaths (RR=1.25; 0.79–1.99) and respiratory failure (RR=1.13;0.57–2.21). The BLVR procedures, especially endobronchial coils, were found to be effective in the management of patients with severeemphysema irrespective of collateral ventilation. However, characterization of patients who would be most benefited from these procedures is required, and effectiveness of these procedures in long run needs to be established.

🔖

Cite This Article

RUSTAGİ, N., SINGH, S., DUTT, N., KUWAL, A., CHAUDHRY, K., SHEKHAR, S., KİRUBAKARAN, R. (2019). Efficacy and Safety of Stent, Valves, Vapour ablation, Coils and Sealant Therapies in Advanced Emphysema: A Meta-Analysis. Turkish Thoracic Journal, Cilt: 20 - Sayı: 1, 43–60. https://ajindex.com/articles/418013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. WHO. Burden of COPD. WHO. [cited 2016 Feb 7]. Available from:
  2. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema. N England J Med 2003;348:2059-73. [CrossRef] 3. Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014;69:280-6. [CrossRef] 4. Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010;4:225-31. [CrossRef] 5. Slebos DJ, Klooster K, Ernst A, et al. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012;142:574-82. [CrossRef] 6. Snell G, Herth FJF, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012;39:1326-33. [CrossRef] 7. Gompelmann D, Heussel CP, Eberhardt R, et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respir Int Rev Thorac Dis 2012;83:400-6. [CrossRef] 8. Kramer MR, Refaely Y, Maimon N, et al. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012;142:1111-7. [CrossRef] 9. Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011;378:997-1005. [CrossRef] 10. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100. [CrossRef] 11. Review Groups. Cochrane. [cited 2016 Oct 24]. Available from:
  3. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
  4. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014
  5. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Front Matter. In: Introduction to Meta-Analysis. John Wiley & Sons, Ltd; 2009. p. i–xxix. Available from: http://dx.doi. org/10.1002/9780470743386.fmatter [CrossRef] 15. Come